annb0t
Top 20
MELBOURNE, Australia, July 23, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX) (Telix, the Company, the Issuer) today launches an offering of A$600 million of convertible notes due 2029 (the Offering). The convertible notes, also referred to as "convertible bonds" (Convertible Bonds), are convertible into fully paid ordinary shares in Telix (Ordinary Shares). (PRNewsfoto/Telix Pharmaceuticals Limited)
Managing Director and Group CEO Dr. Christian Behrenbruch said: "Telix's strong ...
>>> Read more: Telix Announces A$600 Million Convertible Bonds Offering
Managing Director and Group CEO Dr. Christian Behrenbruch said: "Telix's strong ...
>>> Read more: Telix Announces A$600 Million Convertible Bonds Offering
